Page 562 - Williams Hematology ( PDFDrive )

536 Part VI: The Erythrocyte Chapter 35: Aplastic Anemia: Acquired and Inherited 537

C-conditioned Fancc(−/−) mouse model, while long-term treatment is ineffective. 295. Ganapathi KA, Shimamura A: Ribosomal dysfunction and inherited marrow failure. Br
Blood 100:1499, 2002. J Haematol 141:376, 2008.
265. Alter BP: Cancer in Fanconi anemia. Cancer 97:425, 2003. 296. Ganapathi KA, Austin KM, Lee CS, et al: The human Shwachman-Diamond syndrome
266. Alter BP, Caruso JP, Drachtman RA, et al: Fanconi anemia: Myelodysplasia as a predic- protein, SBDS, associates with ribosomal RNA. Blood 110:1458, 2007.
tor of outcome. Cancer Genet Cytogenet 117:125, 2000. 297. Myers KC, Davies SM, Shimamura A: Clinical and molecular pathophysiology of
267. Gluckman E, Wagner JE: Hematopoietic stem cell transplantation in childhood inher- Shwachman-Diamond syndrome: An update. Hematol Oncol Clin North Am 27:117,
ited bone marrow failure syndrome. Bone Marrow Transplant 41:127, 2008. 2013.
268. Huck K, Hanenberg H, Nürnberger W, et al: Favourable long-term outcome after 298. Toiviainen-Salo S, Durie PR, Numminen K, et al: The natural history of Shwachman
matched sibling transplantation for Fanconi-anemia (FA) and in vivo T-cell depletion. Diamond syndrome associated liver disease from childhood to adulthood. J Pediatr
Klin Padiatr 220:147, 2008. 155:807, 2009.
269. Ayas M, Al-Jefri A, Al-Seraihi A, et al: Second stem cell transplantation in patients 299. Dror Y, Durie P, Ginzberg H, et al: Clonal evolution in marrows of patients with
with Fanconi anemia using antithymocyte globulin alone for conditioning. Biol Blood Shwachman-Diamond syndrome: A prospective 5-year follow-up study. Exp Hematol
Marrow Transplant 14:445, 2008. 30:659, 2002.
270. Kelly PF, Radtke S, von Kalle C, et al: Stem cell collection and gene transfer in Fanconi 300. Woloszynek JR, Rothbaum RJ, Rawis AS, et al: Mutations of the SBDS gene are present
anemia. Mol Ther 15:211, 2007. in most patients with Shwachman-Diamond syndrome. Blood 104:3588, 2004.
271. Dufour C, Svahn J: Fanconi anaemia: New strategies. Bone Marrow Transplant 41(Suppl 301. Bhatla D, Davies SM, Shenoy S, et al: Reduced-intensity conditioning is effective and
2):S90, 2008. safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Mar-
272. Dokal I: Dyskeratosis congenita in all its forms. Br J Haematol 110:768, 2000. row Transplant 42:159, 2008.
273. Nelson ND, Bertuch AA: Dyskeratosis congenita as a disorder of telomere mainte- 302. Dokal I, Rule S, Chen F, et al: Adult onset of acute myeloid leukaemia (M6) in patients
nance. Mutat Res 730:43, 2012. with Shwachman-Diamond syndrome. Br J Haematol 99:171, 1997.
274. Savage SA, Alter BP: The role of telomere biology in bone marrow failure and other 303. Dror Y, Squire J, Durie P, Freedman MH: Malignant myeloid transformation with
disorders. Mech Ageing Dev 129(1–2):35, 2008. isochromosome 7q in Shwachman-Diamond syndrome. Leukemia 12:1591, 1998.
275. Keller RB, Gagne KE, Usmani GN, et al: Mutations in a patient with dyskeratosis con- 304. Thornely I, Dror Y, Sung L, et al: Abnormal telomere shortening in leukocytes of chil-
genita. Pediatr Blood Cancer 59:311, 2012. dren with Shwachman-Diamond syndrome. Br J Haematol 117:189, 2002.
276. Ballew B, Yeager M, Jacobs K, et al: Germline mutations of regulator of telomere elon- 305. Geddis AE: Inherited thrombocytopenia: Congenital amegakaryocytic thrombocy-
gation helicase 1, RTEL1, in dyskeratosis congenital. Hum Genet 132:473, 2013. topenia and thrombocytopenia with absent radii. Semin Hematol 43:196, 2006.
277. Vulliamy A, Marrone F, Goldman A, et al: The RNA component of telomerase is 306. Germeshausen M, Ballmaier M, Welte K: MPL mutations in 23 patients suffering from
mutated in autosomal dominant dyskeratosis congenital. Nature 413:432, 2001. congenital amegakaryocytic thrombocytopenia: The type of mutation predicts the
278. Dokal I, Vulliamy T, Mason P, Bessler M: Clinical utility gene card for: Dyskeratosis con- course of the disease. Hum Mutat 27:296, 2006.
genital. Eur J Hum Genet Sep 3, 2014. doi: 10.1038/ejhg.2014.170. [Epub ahead of print]. 307. King S, Germeshausen M, Strauss G, et al: Congenital amegakaryocytic thrombocy-
279. Walne A, Bhagat T, Kirwan M, et al: Mutations in the telomere capping complex in topenia: A retrospective clinical analysis of 20 patients. Br J Haematol 131:636, 2005.
bone marrow failure and related syndromes. Haematologica 98:334, 2013. 308. Stephan JL, Vlekova V, Le Deist F, et al: Severe combined immunodeficiency: A ret-
279a. Ruggero D, Shimamura A. Marrow failure: A window into ribosome biology. Blood rospective single-center study of clinical presentation and outcome in 117 patients. J
124:2784, 2014. Pediatr 123:564, 1993.
280. Savage SA, Giri N, Baerlocher GM, et al: TINF2, a component of the shelterin telomere 309. Bertrand Y, Muller SM, Casanova JL, et al: Reticular dysgenesis: HLA non-identical
protection complex, is mutated in dyskeratosis congenital. Am J Hum Genet 82:501, bone marrow transplants in a series of 10 patients. Bone Marrow Transplant 29:759,
2008. 2002.
281. Walne AJ, Vulliamy T, Marrone A, et al: Genetic heterogeneity in autosomal recessive 310. Esperou-Bourdeau H, Leblanc T, Schaison G, et al: Aplastic anemia associated with
dyskeratosis congenita with one subtype due to mutations in the telomerase-associated “bird-headed” dwarfism (Seckel syndrome). Nouv Rev Fr Hematol 35:99, 1993.
protein NOP10. Hum Mol Genet 16:1619, 2007. 311. O’Driscoll M, Ruiz-Perez VL, Woods CG, et al: A splicing mutation affecting expres-
282. Vulliamy T, Beswick R, Kirwan M, et al: Mutations in the telomerase component of sion of ataxia-telangiectasia and RAD3-related protein (ATR) results in Seckel syn-
NHP2 cause the premature aging syndrome, dyskeratosis congenital. Proc Natl Acad drome. Nat Genet 33:497, 2003.
Sci U S A 105:8073, 2008. 312. Griffith E, Walker S, Martin CA, et al: Mutations in pericentrin cause Seckel syndrome
283. Vulliamy T, Marrone A, Szydlo R, et al: Disease anticipation is associated with progres- with defective ATR-dependent DNA damage signaling. Nat Genet 40:232, 2008.
sive telomere shortening in families with dyskeratosis congenital due to mutations in 313. Hayani A, Suarez CR, Molnar Z, et al: Acute myeloid leukemia in a patient with Seckel
TERC. Nat Genet 36:447, 2004. syndrome. J Med Genet 31:148, 1994.
284. Alter BP, Baerlocher GM, Savage SA, et al: Very short telomere length by flow fluo- 314. O’Driscoll M, Gennery AR, Seidel J, et al: An overview of three new disorders asso-
rescence in situ hybridization identifies patients with dyskeratosis congenita. Blood ciated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome.
110:1439, 2007. DNA Repair (Amst) 3:1227, 2004.
285. Ghavamzadeh A, Alimoghadam K, Nasseri P, et al: Correction of bone marrow failure 315. Li FP, Hecht F, Kaiser-McCaw B, et al: Ataxia-pancytopenia: Syndrome of cerebellar
in dyskeratosis congenita by bone marrow transplantation. Bone Marrow Transplant ataxia, hypoplastic anemia, monosomy 7 and acute myelogenous leukemia. Cancer
23:299, 1999. Genet Cytogenet 4:189, 1981.
286. Cesaro S, Oneto R, Messina C, et al: Haematopoietic stem cell transplantation for 316. Mahmood F, King MD, Smyth OO, et al: Familial cerebellar hypoplasia and pancytope-
Shwachman-Diamond disease: A study from the European Group for Blood and Mar- nia without chromosomal breakages. Neuropediatrie 29:302, 1998.
row Transplantation. Br J Haematol 131:231, 2005. 317. González-del AA, Cervera M, Gomez L, et al: Ataxia-pancytopenia syndrome. Am J
287. Güngör T, Corbacioglu S, Storb R, Seger RA: Nonmyeloablative allogeneic hemato- Med Genet 90:252, 2000.
poietic stem cell transplantation for treatment of dyskeratosis congenita. Bone Marrow 318. Pierce AJ, Jasin M: NHEJ deficiency and disease. Mol Cell 8:1160, 2001.
Transplant 31:407, 2003. 319. O’Driscoll M, Jeggo PA: CSA can induce DNA double-strand breaks: Implications for
288. Dror Y, Freedman MH, Leaker M, et al: Low-intensity hematopoietic stem-cell trans- BMT regimens particularly for individuals with defective DNA repair. Bone Marrow
plantation across human leucocyte antigen barriers in dyskeratosis congenita. Bone Transplant 41:983, 2008.
Marrow Transplant 31:847, 2003. 320. Walters TR, Desposito F: Aplastic anemia in Dubowitz syndrome. J Pediatr 106:622,
289. Alter BP, Neelam G, Savage SA, et al: Cancer in dyskeratosis congenital. Blood 113:6549, 1985.
2009. 321. Berthold F, Fuhrmann W, Lampert F: Fatal aplastic anemia in a patient with Dubowitz
290. Goobie S, Popovic M, Morrison J, et al: Shwachman Diamond syndrome with exocrine syndrome. Eur J Pediatr 146:605, 1987.
pancreatic dysfunction and bone marrow failure maps to the centromeric region of 322. Gennery AR, Slatter MA, Bhattacharya A, et al: The clinical and biological overlap
chromosome 7. Am J Hum Genet 68:1048, 2001. between Nijmegen breakage syndrome and Fanconi anemia. Clin Immunol 113:214,
291. Ginzberg H, Shin J, Ellis L, et al: Shwachman syndrome: Phenotypic manifestations of 2004.
sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 135:81, 1999. 323. Gadkowska-Dura M, Dzieranowska-Fangrat K, Dura W, et al: Unique morphological
292. Shimamura A: Shwachman-Diamond syndrome. Semin Hematol 43:178, 2006. spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high fre-
293. Rujkijyanont P, Watanabe K, Ambekar C, et al: SBDS-Deficient cells undergo acceler- quency of consecutive lymphoma formation. J Pathol 216:337, 2008.
ated apoptosis through the FAS pathway. Haematologica 93:363, 2008. 324. Gonzalez CH, Durkin-Stamm MV, Geimer NF, et al: The WT syndrome—A “new”
294. Thornley I, Dror Y, Sung L, et al: Abnormal telomere shortening in leucocytes of chil- autosomal dominant pleiotropic trait of radial/ulnar hypoplasia with high risk of bone
dren with Shwachman-Diamond syndrome. Br J Haematol 117:189, 2002. marrow failure and/or leukemia. Birth Defects Orig Artic Ser 13:31, 1977.

Kaushansky_chapter 35_p0513-0538.indd 537 9/19/15 12:24 AM